Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform

3 months ago

ACTON, Mass. and YAMANASHI, Japan, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), a medical diagnostics…

U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast tablets) as first new treatment option for adults with IPF in over a decade

3 months ago

Ingelheim, Germany/Ridgefield, Connecticut, U.S. Idiopathic pulmonary fibrosis (IPF) is a progressive disease, causing a continuous decline in lung function.1Approval is…

Akero Therapeutics to be Acquired by Novo Nordisk for up to $5.2 Billion

3 months ago

Shareholders to Receive $54 Per Share in Cash and CVR of $6 Per Share  Advances Akero’s Mission of Bringing Novel…

Human Appeal’s Pot of Gold Film to Air on EarthX Channel on October 18

3 months ago

BayView Entertainment to Bring Groundbreaking Documentary to Streaming and Broadcast Audiences Pot of Gold Film to Air on EarthX Channel…

Novo Nordisk to acquire Akero Therapeutics and its promising phase 3 FGF21 analogue to expand MASH portfolio

3 months ago

Acquisition adds potential first- and best-in-class asset, enhancing Novo Nordisk’s portfolio for treatment of MASH, one of the most prevalent…

Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial

3 months ago

STAFFORD, Texas, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused…

Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer

3 months ago

VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse…

Italfarmaco Appoints Francesco Di Marco as Chief Executive Officer

3 months ago

MILAN, Italy, October 09, 2025 – Italfarmaco S.p.A. today announced that Dr. Francesco Di Marco has been appointed as Chief…

Tensive publishes positive long-term clinical follow-up data in Breast Cancer on REGENERA™ / SOFTAG™ breast implant

3 months ago

24-month Phase I follow-up data show positive outcomes are maintained High levels of investigator and patient satisfaction, excellent safety profileOngoing registrational…

Advantech AOM-5721 Combines SMARC Design and Qualcomm Dragonwing™ QCS6490 for Next-Gen Edge AI

3 months ago

TAIPEI, Oct. 9, 2025 /PRNewswire/ -- Advantech (TWSE: 2395), a global leader in edge computing and AI solutions, is proud…